The World Health Organization declared the Ebola outbreak in eastern Congo and Uganda a public health emergency of international concern on May 16. With Bundibugyo ebolavirus and no vaccine or treatment available, containment now depends on a kind of workforce
On May 16, the World Health Organization declared the Ebola outbreak in eastern Congo and Uganda a public health emergency of international concern. The decision came from Director-General Tedros Adhanom Ghebreyesus, who made the determination before convening an emergency committee.
By May 17, the WHO and Africa Centres for Disease Control and Prevention reported at least 246 suspected cases and 80 suspected deaths. The virus strain is Bundibugyo ebolavirus, a species for which no vaccine or treatment exists.
In Uganda, the outbreak has reached Kampala with two unlinked laboratory-confirmed cases, including one death.
The outbreak is now running into a reality that responders who have fought prior viral hemorrhagic fever outbreaks recognize too well: containment is less about one heroic intervention and more about a steady, trained system—something that, in this moment, is under strain.
The structural conditions are there. Kampala is a major international travel hub. Migrant gold miners travel in and out of Mongwalu, identified as one of the epicenters. Refugee camps sit along the border with South Sudan.
Armed militants control parts of the outbreak zone. The outbreak festered for months before anyone confirmed what it was. A local health system has already collapsed, with clinics without drugs, personal protective equipment stockpiles gone, and trained staff laid off.
And while Ebola spreads regardless of politics, the U.S. has been stepping back in ways that ripple through the logistics of containment.
The United States withdrew from the WHO in January. USAID, which had funded contact tracers, border screeners, lab workers and response capacity across central Africa, was dissolved last July. Under that change, 80% of its global health awards were terminated and $12.7 billion was gone.
At the Centers for Disease Control and Prevention, a Senate-confirmed director held the job for only about a month under this administration, and it currently has no Senate-confirmed leader in place. The Department of Health and Human Services has lost more than 10,000 employees.
National Institutes of Health laboratories that provided vital support have been closed or defunded. HHS Secretary Robert F. Kennedy Jr. had once promised to give infectious disease research “a break for about eight years.”
The sequencing of facts is blunt: a major emergency is declared as case counts rise, but the institutions and workforce needed to move fast—screening, tracing, lab turnaround, frontline staffing—have been disrupted.
Containing Ebola is, at its core, a workforce equation. One nurse in full protective equipment can deliver 100 milliliters of IV fluid to one patient in one hour. One nurse can also sit outside the unit and coach 10 patients to drink a liter of fluids each.
During the West Africa epidemic, fluids coaching was the approach chosen because it scaled. The community health workers trained for that role had their positions eliminated when USAID funding ended.
In West Africa, blood samples took four days to return. People waited in suspected case wards for confirmation. Some contracted Ebola while waiting to find out if they had it. As of right now, only a small proportion have been tested, and the bottleneck that killed people in 2014 is already forming.
Early Ebola symptoms can look like malaria, typhoid and labor pains. Health care workers died on delivery wards in West Africa because they were attending births, not women with Ebola.
In Ituri, clinicians with limited protective equipment are seeing patients with nonspecific symptoms in an area where malaria is everywhere. The early signal is described as indistinguishable from noise.
The comparison goes beyond medicine. It reaches trust.
Communities in West Africa had a phrase for what happened when foreign aid workers arrived: “Ebola business.” The nongovernmental organizations came with 4x4s and large contracts. Then the outbreak ended, and they left.
In eastern Congo, the distrust runs deeper. About $800 million went toward a treatment developed partly from a Congolese survivor’s blood. Yet Congolese patients in subsequent outbreaks struggled to access what their bodies helped create.
The region’s security situation also complicates any attempt to restore routine care. Rwanda-backed M23 rebels have seized territory across the region, and United Nations investigators have documented mineral smuggling at “unprecedented levels.”
In December, President Donald Trump hosted the leaders of Rwanda and the Democratic Republic of the Congo at the White House and announced that U.S. companies would extract rare-earth minerals in both countries. To Congolese people, that looked like America negotiating with their occupier.
M23 seized Goma, eastern Congo’s largest city, the same week USAID funding was frozen, and the change helped collapse the pharmacy system that supplied medicine to rural clinics.
An estimated 300,000 people have died from treatable diseases since—deaths described as coming not from Ebola or bullets, but from a health system that stopped working.
Bundibugyo ebolavirus has caused only two recognized outbreaks before, but this is already the largest outbreak. The entire countermeasure pipeline—vaccines. therapeutics. diagnostics—was built for the Zaire species. which is more than 40% genetically different. leaving “nothing in development” close to ready.
That means responders are left with the same basic tools available when Ebola first emerged in 1976: find the sick, isolate them, trace their contacts, and bury the dead safely.
Those steps require trained people, trusted people, and funded people—the very jobs described as being cut.
Dr. Céline Gounder, an infectious disease specialist and epidemiologist, describes the situation not as a prediction, but as a record. The outbreak is meeting rapidly spreading conditions in a place where containment was difficult enough when institutions were intact.
Gounder served on the Biden administration transition team’s COVID-19 advisory board. Drs. Craig Spencer, Angela Rasmussen, Krutika Kruppalli, Nahid Bhadelia and Megan Coffee contributed to the research for the column.
Ebola Bundibugyo ebolavirus WHO Tedros Adhanom Ghebreyesus Congo Uganda Kampala USAID CDC HHS public health emergency contact tracing diagnostics therapeutics workforce capacity